These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 22464718)
1. Transjugular intrahepatic portosystemic shunt occlusion via modified pringle maneuver for radiofrequency ablation of nearby tumor. Pua U; Punamiya S J Vasc Interv Radiol; 2012 Apr; 23(4):563-5. PubMed ID: 22464718 [No Abstract] [Full Text] [Related]
2. Radiofrequency Ablation for the Treatment of Hepatocellular Carcinoma in Patients with Transjugular Intrahepatic Portosystemic Shunts. Park JK; Al-Tariq QZ; Zaw TM; Raman SS; Lu DS Cardiovasc Intervent Radiol; 2015 Oct; 38(5):1211-7. PubMed ID: 25670215 [TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Microwave Ablation for Hepatocellular Carcinoma in the Setting of Transjugular Intrahepatic Portosystemic Shunt. Yan J; Ying X; Malhotra A; Talenfeld A; Charalel R; Lee KS; Trost D; Kesselman A Cardiovasc Intervent Radiol; 2022 May; 45(5):578-581. PubMed ID: 34859308 [TBL] [Abstract][Full Text] [Related]
4. A double-wire technique for transjugular intrahepatic portosystemic shunt through a transabdominal-transjugular portosystemic approach. Yu SC AJR Am J Roentgenol; 2011 Jul; 197(1):W181-3. PubMed ID: 21700983 [TBL] [Abstract][Full Text] [Related]
5. Re: irreversible electroporation of a hepatocellular carcinoma lesion adjacent to a transjugular intrahepatic portosystemic shunt stent graft. Pua U Korean J Radiol; 2014; 15(1):181. PubMed ID: 24497813 [No Abstract] [Full Text] [Related]
6. Irreversible electroporation of a hepatocellular carcinoma lesion adjacent to a transjugular intrahepatic portosystemic shunt stent graft. Niessen C; Jung EM; Wohlgemuth WA; Trabold B; Haimerl M; Schreyer A; Stroszczynski C; Wiggermann P Korean J Radiol; 2013; 14(5):797-800. PubMed ID: 24043975 [TBL] [Abstract][Full Text] [Related]
7. Outcomes of Locoregional Tumor Therapy for Patients with Hepatocellular Carcinoma and Transjugular Intrahepatic Portosystemic Shunts. Padia SA; Chewning RH; Kogut MJ; Ingraham CR; Johnson GE; Bhattacharya R; Kwan SW; Monsky WL; Vaidya S; Hippe DS; Valji K Cardiovasc Intervent Radiol; 2015 Aug; 38(4):913-21. PubMed ID: 25373795 [TBL] [Abstract][Full Text] [Related]
8. Local tumor progression after radiofrequency ablation of liver tumors: analysis of morphologic pattern and site of recurrence. Kei SK; Rhim H; Choi D; Lee WJ; Lim HK; Kim YS AJR Am J Roentgenol; 2008 Jun; 190(6):1544-51. PubMed ID: 18492905 [TBL] [Abstract][Full Text] [Related]
9. Transjugular intrahepatic portosystemic shunt for intractable posthepatectomy ascites. Hwang S; Park KM; Lee SG; Sung KB; Lee YJ; Choi DN; Ahn CS; Min PC Hepatogastroenterology; 2002; 49(48):1669-72. PubMed ID: 12397761 [TBL] [Abstract][Full Text] [Related]
10. Influence of the transjugular intrahepatic portosystemic stent on firstline treatment of hepatocellular carcinoma. Knüppel E; Bettinger D; Euringer W; Thimme R; Roessle M; Spangenberg HC; Schultheiβ M Hepatology; 2013 Dec; 58(6):2211-2. PubMed ID: 23519917 [No Abstract] [Full Text] [Related]
11. [How to do: Radiofrequency thermal ablation]. Schultheiß M; Thimme R Dtsch Med Wochenschr; 2015 Jan; 140(1):36-8. PubMed ID: 25580971 [No Abstract] [Full Text] [Related]